Trial Profile
The comparative effect of combination chemotherapy with Paclitaxel (Taxol) and Gemcitabine vs Taxol and Vinorelbine on survival in non-operable non-small cell lung cancer stage IIIBw and IV, PS : 0, 1. A Phase III randomized study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Sep 2010 Primary endpoint 'Overall-survival-rate' has not been met, according to Annals of Oncology publication.
- 29 Sep 2010 Primary endpoint 'Overall-survival-duration' has not been met, according to Annals of Oncology publication.
- 29 Sep 2010 Results were published in the Annals of Oncology.